Materialise buys majority stake in Engimplan, expands medical 3D printing business in Brazil
Summary
Belgian software and 3D printing service provider Materialise has acquired a 75 percent stake in Engimplan, a Brazil-based medical device manufacturer. “This investment by Materialise sends a strong signal to our customers and the industry that we remain committed to developing our innovative solutions that improve the lives of many people, and that we have the confidence and support of a pioneer and global leader in 3D printing,” explains José Tadeu Leme, CEO of Engimplan. “Surgical planning and 3D printing are increasingly adopted by orthopedic and CMF surgeons, as they understand the positive impact of personalized implants and patient-specific solutions on surgical outcomes,” comments Brigitte de Vet, Vice President and General Manager of Materialise Medical. For nearly 30 years, Materialise has placed a substantial effort in developing certified medical solutions, with the aim of helping researchers, engineers and clinicians achieve their desired patient outcomes. In June 2019, Materialise received additional clearance from the FDA for Mimics Enlight, a 3D modeling software for planning cardiovascular surgery.
Classifications
AskAI Classifications
LabelsLinked Companies
